Publication: Emetine regulates the alternative splicing of caspase 9 in tumor cells
1
Issued Date
2011-11-01
Resource Type
ISSN
17921082
17921074
17921074
Other identifier(s)
2-s2.0-80052708840
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Oncology Letters. Vol.2, No.6 (2011), 1309-1312
Suggested Citation
Danmin Pan, Kritsanapol Boon-Unge, Piyarat Govitrapong, Jianhua Zhou Emetine regulates the alternative splicing of caspase 9 in tumor cells. Oncology Letters. Vol.2, No.6 (2011), 1309-1312. doi:10.3892/ol.2011.395 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/11444
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Emetine regulates the alternative splicing of caspase 9 in tumor cells
Other Contributor(s)
Abstract
Exons 3 to 6 in the caspase 9 gene undergo alternative splicing in which the larger caspase 9 splice variant promotes apoptosis, in contrast to the dominant negative anti-apoptotic splice variant, the smaller caspase 9b. In this study, the regulation of the alternative splicing of caspase 9 pre-mRNA was examined in response to Emetine. Treatment of C33A cells, breast cancer MCF-7 cells and MCF-7/Adr cells with Emetine dihydrochloride upregulated the level of smaller caspase 9b mRNA and concomitantly decreased the mRNA level of larger caspase 9 in a dose- and time-dependent manner, indicating that Emetine desensitizes C33A, MCF-7 and MCF-7/Adr to cell death. In contrast, treatment of PC3 cells, a prostate cancer cell line, manifested an opposite effect: a greater production of the larger caspase 9 mRNA with a concomitant decrease of caspase 9b mRNA. Pretreatment with calyculin A, an inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) blocked Emetine-induced alternative splicing in cells, in contrast to okadaic acid, a specific inhibitor of PP2A, demonstrating a PP1-mediated mechanism. These results suggest that the various splicing patterns of the caspase 9 gene that are regulated by chemotherapy reagents may contribute to the resistance or sensitization of the tumors to other cell death inducers.